Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
Menu

Contact Us
If you have any questions or feedback please contact us.
 Back to Profile

Sharon Pine

Concepts (308)

Concepts are derived automatically from a person's publications.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Lung Neoplasms
32
2025
2554
3.010
 Why?
Carcinoma, Non-Small-Cell Lung
10
2025
1125
1.530
 Why?
Biomarkers, Tumor
12
2025
1250
1.170
 Why?
Amyloid Precursor Protein Secretases
3
2018
78
1.160
 Why?
SOX9 Transcription Factor
3
2023
26
1.130
 Why?
Leukemia, Megakaryoblastic, Acute
4
2007
10
0.820
 Why?
Receptor, Notch1
2
2014
65
0.810
 Why?
GATA1 Transcription Factor
4
2007
18
0.780
 Why?
DNA, Neoplasm
4
2010
159
0.730
 Why?
STAT Transcription Factors
1
2021
16
0.730
 Why?
Janus Kinases
1
2021
15
0.730
 Why?
Paclitaxel
2
2022
236
0.670
 Why?
Signal Transduction
9
2021
5116
0.640
 Why?
Carcinoma, Squamous Cell
4
2025
641
0.630
 Why?
Neoplastic Stem Cells
3
2013
411
0.580
 Why?
Inflammation
4
2022
2840
0.570
 Why?
Protease Inhibitors
1
2018
102
0.550
 Why?
Benzodiazepinones
1
2017
18
0.550
 Why?
Neoplasms
4
2025
2731
0.530
 Why?
Gene Expression Regulation, Neoplastic
9
2025
1439
0.530
 Why?
Cell Line, Tumor
13
2023
3502
0.510
 Why?
Antineoplastic Agents
7
2023
2162
0.510
 Why?
Down Syndrome
4
2007
504
0.500
 Why?
F-Box Proteins
1
2016
21
0.500
 Why?
Antineoplastic Agents, Phytogenic
1
2017
192
0.490
 Why?
Precursor Cell Lymphoblastic Leukemia-Lymphoma
3
2005
288
0.480
 Why?
Proteasome Endopeptidase Complex
1
2016
159
0.460
 Why?
Drug Resistance, Neoplasm
6
2021
840
0.460
 Why?
Polymerase Chain Reaction
5
2010
1050
0.450
 Why?
Ubiquitin-Protein Ligases
1
2016
174
0.450
 Why?
Interleukin-8
3
2014
268
0.450
 Why?
Neoplasms, Basal Cell
1
2013
3
0.420
 Why?
Chromosome Segregation
1
2013
46
0.410
 Why?
DNA Damage
1
2016
430
0.410
 Why?
DNA
2
2022
1440
0.370
 Why?
Cell Cycle Proteins
1
2016
628
0.370
 Why?
Interleukin-6
3
2019
775
0.370
 Why?
C-Reactive Protein
2
2011
416
0.360
 Why?
Adenocarcinoma
3
2017
897
0.350
 Why?
Mannose-Binding Lectin
2
2009
20
0.350
 Why?
Proto-Oncogene Proteins c-mdm2
2
2012
65
0.330
 Why?
Smoking
6
2024
1576
0.330
 Why?
Humans
52
2025
141284
0.330
 Why?
Oncogene Proteins, Fusion
3
2017
205
0.330
 Why?
Case-Control Studies
14
2024
3577
0.320
 Why?
Cell Transformation, Neoplastic
2
2021
334
0.320
 Why?
Mutation
9
2023
4006
0.310
 Why?
Polymorphism, Single Nucleotide
6
2019
2122
0.300
 Why?
Mice
12
2023
17969
0.290
 Why?
Polymorphism, Genetic
2
2009
619
0.280
 Why?
Cytokines
1
2015
2079
0.270
 Why?
Inflammation Mediators
2
2021
507
0.270
 Why?
Proto-Oncogene Proteins p21(ras)
3
2023
249
0.270
 Why?
Lymphoma, AIDS-Related
1
2007
14
0.260
 Why?
Molecular Targeted Therapy
2
2021
420
0.260
 Why?
Lymphoproliferative Disorders
1
2007
60
0.250
 Why?
Animals
14
2023
37328
0.250
 Why?
Leukemia
2
2007
243
0.250
 Why?
Lymphoma, Non-Hodgkin
1
2007
123
0.240
 Why?
Nuclear Weapons
1
2025
7
0.240
 Why?
Cell Proliferation
7
2021
2502
0.230
 Why?
Neoplasms, Radiation-Induced
1
2025
98
0.220
 Why?
Breast Neoplasms
2
2013
2246
0.210
 Why?
Female
31
2025
75814
0.210
 Why?
Carboplatin
2
2022
145
0.210
 Why?
Smokers
1
2024
146
0.200
 Why?
Tumor Microenvironment
3
2023
711
0.200
 Why?
Genes, ras
1
2023
94
0.200
 Why?
Aged
19
2024
24836
0.200
 Why?
Alternative Splicing
1
2025
232
0.190
 Why?
Central Nervous System Neoplasms
1
2005
169
0.190
 Why?
Base Sequence
4
2014
2170
0.180
 Why?
Class I Phosphatidylinositol 3-Kinases
1
2022
100
0.180
 Why?
Intracellular Signaling Peptides and Proteins
2
2022
465
0.180
 Why?
Epithelial-Mesenchymal Transition
2
2014
213
0.180
 Why?
Mechanistic Target of Rapamycin Complex 1
1
2022
131
0.180
 Why?
Cell Movement
3
2020
962
0.180
 Why?
Pyrazines
1
2022
88
0.180
 Why?
Ribosome Subunits, Large, Eukaryotic
1
2021
3
0.180
 Why?
Superoxide Dismutase-1
1
2021
12
0.180
 Why?
Organelle Biogenesis
1
2021
15
0.170
 Why?
Immunity, Innate
1
2007
847
0.170
 Why?
Triazoles
1
2022
163
0.170
 Why?
Cytokinesis
1
2021
50
0.170
 Why?
Middle Aged
18
2024
34658
0.170
 Why?
Adenocarcinoma, Mucinous
1
2021
76
0.170
 Why?
Phosphatidylinositol 3-Kinases
1
2022
364
0.160
 Why?
Prognosis
7
2024
4080
0.160
 Why?
Receptors, Kisspeptin-1
1
2020
2
0.160
 Why?
Male
25
2025
70140
0.160
 Why?
Proto-Oncogene Proteins c-akt
1
2022
438
0.160
 Why?
Receptor-Like Protein Tyrosine Phosphatases, Class 2
1
2019
10
0.160
 Why?
Molecular Sequence Data
3
2014
2911
0.160
 Why?
Janus Kinase 2
1
2019
32
0.160
 Why?
Disease Susceptibility
1
2021
351
0.160
 Why?
Molecular Chaperones
1
2021
198
0.150
 Why?
Mice, Inbred NOD
2
2020
599
0.150
 Why?
Cellular Senescence
2
2013
218
0.150
 Why?
TOR Serine-Threonine Kinases
1
2022
428
0.150
 Why?
Biomarkers
2
2021
4180
0.150
 Why?
Cellular Reprogramming
1
2020
100
0.150
 Why?
Neoplasm, Residual
3
2005
130
0.150
 Why?
Acrylamides
1
2019
67
0.150
 Why?
Combined Modality Therapy
1
2021
1243
0.140
 Why?
Nanotechnology
1
2019
125
0.140
 Why?
Aniline Compounds
1
2019
120
0.140
 Why?
Proteolysis
2
2016
173
0.140
 Why?
Carcinogenesis
1
2020
218
0.140
 Why?
Quinolines
1
2019
169
0.140
 Why?
Risk Factors
8
2015
10490
0.140
 Why?
Receptors, Notch
1
2018
87
0.140
 Why?
Transcriptome
1
2024
1007
0.140
 Why?
Quinazolines
1
2019
260
0.140
 Why?
Lung
4
2022
4051
0.140
 Why?
Transfection
2
2017
932
0.130
 Why?
Tumor Suppressor Protein p53
2
2013
528
0.130
 Why?
Disease Management
1
2021
634
0.130
 Why?
Cancer Survivors
1
2022
281
0.130
 Why?
Triple Negative Breast Neoplasms
1
2020
201
0.130
 Why?
CD24 Antigen
2
2013
19
0.130
 Why?
F-Box-WD Repeat-Containing Protein 7
1
2016
6
0.130
 Why?
Neoplasm Invasiveness
2
2020
510
0.130
 Why?
Hyaluronan Receptors
2
2013
103
0.120
 Why?
Glycogen Synthase Kinase 3 beta
1
2016
73
0.120
 Why?
Ubiquitination
1
2016
107
0.120
 Why?
Coculture Techniques
2
2013
244
0.120
 Why?
Proportional Hazards Models
2
2011
1268
0.120
 Why?
Protein Interaction Domains and Motifs
1
2016
150
0.120
 Why?
Cell Division
3
2013
792
0.110
 Why?
Proto-Oncogene Proteins B-raf
1
2017
225
0.110
 Why?
Receptors, Interleukin-8B
1
2014
24
0.110
 Why?
Protein Kinase Inhibitors
2
2019
918
0.110
 Why?
Cell Death
1
2016
386
0.110
 Why?
Protein Isoforms
2
2013
397
0.110
 Why?
Computational Biology
1
2019
663
0.110
 Why?
Patient Selection
1
2018
685
0.110
 Why?
Tumor Cells, Cultured
2
2021
959
0.110
 Why?
Gene Expression Profiling
4
2025
1761
0.110
 Why?
Software
1
2019
675
0.110
 Why?
3' Untranslated Regions
1
2014
149
0.110
 Why?
Disease Progression
1
2021
2808
0.100
 Why?
Energy Metabolism
1
2020
926
0.100
 Why?
Ultraviolet Rays
1
2016
399
0.100
 Why?
Colorectal Neoplasms
1
2021
811
0.100
 Why?
Platinum Compounds
1
2013
10
0.100
 Why?
Genes, T-Cell Receptor
2
2003
9
0.100
 Why?
Research Design
2
2011
1105
0.100
 Why?
Dipeptides
1
2013
55
0.100
 Why?
Core Binding Factor Alpha 2 Subunit
2
2003
29
0.100
 Why?
Immunoglobulin Heavy Chains
2
2003
85
0.100
 Why?
Models, Biological
2
2019
1810
0.100
 Why?
Alleles
3
2014
878
0.090
 Why?
Survival Analysis
2
2013
1322
0.090
 Why?
Gene Expression Regulation
1
2021
2600
0.090
 Why?
Stromal Cells
1
2012
117
0.090
 Why?
Gap Junctions
1
2012
63
0.090
 Why?
HIV Infections
1
2007
2981
0.090
 Why?
Genotype
4
2014
1854
0.090
 Why?
Phosphorylation
1
2016
1753
0.090
 Why?
Lymphocytes, Tumor-Infiltrating
1
2013
211
0.090
 Why?
Risk Assessment
3
2011
3522
0.090
 Why?
National Cancer Institute (U.S.)
1
2011
48
0.090
 Why?
Bone Marrow Cells
1
2012
316
0.090
 Why?
Japan
2
2025
134
0.080
 Why?
Cell Communication
1
2012
306
0.080
 Why?
Adult
8
2020
39319
0.080
 Why?
ROC Curve
2
2024
594
0.080
 Why?
Protein Binding
1
2016
2233
0.080
 Why?
Melanoma
1
2017
786
0.080
 Why?
AC133 Antigen
1
2010
20
0.080
 Why?
Bromodeoxyuridine
1
2010
80
0.080
 Why?
Phenotype
3
2013
3172
0.080
 Why?
Biopsy
2
2017
1073
0.080
 Why?
Logistic Models
2
2011
2098
0.070
 Why?
Exons
2
2008
352
0.070
 Why?
Infant
3
2007
9820
0.070
 Why?
DNA Replication
1
2010
237
0.070
 Why?
Genetic Predisposition to Disease
4
2012
2366
0.070
 Why?
Cell Differentiation
2
2008
1983
0.070
 Why?
Glycoproteins
1
2010
354
0.070
 Why?
Polymorphism, Single-Stranded Conformational
1
2007
25
0.070
 Why?
Baltimore
1
2007
68
0.070
 Why?
CD8-Positive T-Lymphocytes
1
2013
911
0.070
 Why?
Smoking Cessation
1
2011
431
0.070
 Why?
Tobacco Smoke Pollution
1
2009
238
0.070
 Why?
Sequence Homology, Nucleic Acid
1
2007
154
0.060
 Why?
Linkage Disequilibrium
1
2007
251
0.060
 Why?
Prospective Studies
2
2011
7805
0.060
 Why?
Antigens, CD
1
2010
537
0.060
 Why?
Autophagy
2
2023
283
0.060
 Why?
DNA Primers
2
2008
507
0.060
 Why?
Infant, Newborn
3
2007
6270
0.060
 Why?
ErbB Receptors
2
2019
612
0.060
 Why?
Neoplasm Staging
3
2017
1397
0.060
 Why?
Superoxide Dismutase
1
2008
346
0.060
 Why?
In Situ Hybridization, Fluorescence
1
2007
310
0.060
 Why?
Haplotypes
1
2007
490
0.060
 Why?
Disease-Free Survival
1
2007
713
0.060
 Why?
Predictive Value of Tests
1
2011
2069
0.060
 Why?
Chromosomes, Human, Pair 21
1
2005
42
0.060
 Why?
Gene Knockdown Techniques
2
2021
331
0.060
 Why?
Preservation, Biological
1
2005
7
0.060
 Why?
United States
3
2020
15298
0.060
 Why?
Remission Induction
1
2005
306
0.060
 Why?
Liquid Biopsy
1
2024
13
0.060
 Why?
Cloning, Molecular
1
2005
531
0.050
 Why?
History, 21st Century
1
2025
218
0.050
 Why?
MicroRNAs
3
2019
693
0.050
 Why?
Tobacco Smoking
1
2024
25
0.050
 Why?
History, 20th Century
1
2025
324
0.050
 Why?
Mice, Knockout
2
2021
3042
0.050
 Why?
Peptides
1
2010
971
0.050
 Why?
Chronology as Topic
1
2003
2
0.050
 Why?
Chromosome Breakage
1
2003
23
0.050
 Why?
Reproducibility of Results
2
2019
3345
0.050
 Why?
Gene Expression
1
2008
1490
0.050
 Why?
Mitogen-Activated Protein Kinase Kinases
1
2023
130
0.050
 Why?
Clone Cells
1
2003
267
0.050
 Why?
Mucins
1
2022
75
0.050
 Why?
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
1
2003
80
0.040
 Why?
Apoptosis
2
2021
2487
0.040
 Why?
Promoter Regions, Genetic
1
2006
1244
0.040
 Why?
Immunophenotyping
1
2003
325
0.040
 Why?
Cell Nucleolus
1
2021
18
0.040
 Why?
Child
4
2009
22390
0.040
 Why?
Adenosine
1
2022
251
0.040
 Why?
RNA Processing, Post-Transcriptional
1
2021
92
0.040
 Why?
Time Factors
1
2011
6951
0.040
 Why?
Mutagenesis, Site-Directed
1
2021
377
0.040
 Why?
Aftercare
1
2022
218
0.040
 Why?
Down-Regulation
1
2022
636
0.040
 Why?
Glutaminase
1
2020
11
0.040
 Why?
Precision Medicine
1
2024
435
0.040
 Why?
Fibrosis
1
2022
541
0.040
 Why?
RNA Precursors
1
2021
156
0.040
 Why?
Africa, Western
1
2019
21
0.040
 Why?
A549 Cells
1
2019
74
0.040
 Why?
Mice, Nude
1
2021
700
0.040
 Why?
Tumor Stem Cell Assay
1
2019
34
0.040
 Why?
Glutamine
1
2020
107
0.040
 Why?
Recurrence
1
2003
1108
0.040
 Why?
Exome
1
2020
235
0.040
 Why?
Nucleotides
1
2020
125
0.040
 Why?
Child, Preschool
2
2005
11511
0.040
 Why?
Mice, SCID
1
2020
367
0.040
 Why?
Killer Cells, Natural
1
2022
467
0.040
 Why?
DNA Mutational Analysis
1
2019
396
0.040
 Why?
Tumor Burden
1
2020
314
0.040
 Why?
Incidence
2
2019
2809
0.040
 Why?
Proto-Oncogene Proteins c-myc
1
2020
163
0.040
 Why?
Survivors
1
2022
501
0.040
 Why?
Xenograft Model Antitumor Assays
1
2021
917
0.030
 Why?
STAT3 Transcription Factor
1
2019
211
0.030
 Why?
Cell Nucleus
1
2021
607
0.030
 Why?
Immunotherapy
1
2022
641
0.030
 Why?
B-Lymphocytes
1
2003
857
0.030
 Why?
DNA-Binding Proteins
1
2005
1483
0.030
 Why?
Genetic Therapy
1
2019
315
0.030
 Why?
Risk
1
2019
903
0.030
 Why?
Young Adult
3
2020
13727
0.030
 Why?
Transcription Factors
1
2005
1706
0.030
 Why?
Health Status Disparities
1
2019
303
0.030
 Why?
Positron Emission Tomography Computed Tomography
1
2017
112
0.030
 Why?
Follow-Up Studies
2
2019
5222
0.030
 Why?
Pyrimidines
1
2019
510
0.030
 Why?
Indoles
1
2019
472
0.030
 Why?
MAP Kinase Signaling System
1
2017
320
0.030
 Why?
Neoplasm Metastasis
1
2017
674
0.030
 Why?
Survival Rate
1
2019
1979
0.030
 Why?
Leupeptins
1
2013
11
0.030
 Why?
Cell Survival
1
2017
1123
0.030
 Why?
Macrolides
1
2013
69
0.030
 Why?
Transduction, Genetic
1
2013
135
0.020
 Why?
Octamer Transcription Factor-3
1
2012
19
0.020
 Why?
Ligands
1
2014
665
0.020
 Why?
Binding Sites
1
2014
1311
0.020
 Why?
Neoplasm Proteins
1
2013
435
0.020
 Why?
Cohort Studies
2
2012
5809
0.020
 Why?
Disease Models, Animal
1
2021
4414
0.020
 Why?
Mice, Inbred C57BL
1
2021
5866
0.020
 Why?
Cross-Sectional Studies
1
2022
5653
0.020
 Why?
Recombinant Proteins
1
2013
1362
0.020
 Why?
Early Detection of Cancer
1
2014
432
0.020
 Why?
Genetic Variation
1
2014
993
0.020
 Why?
Confidence Intervals
1
2010
328
0.020
 Why?
Treatment Outcome
1
2024
11216
0.020
 Why?
Age Distribution
1
2010
396
0.020
 Why?
Sex Distribution
1
2010
381
0.020
 Why?
Small Cell Lung Carcinoma
1
2010
114
0.020
 Why?
Reference Values
1
2010
803
0.020
 Why?
Enzyme Stability
1
2008
71
0.020
 Why?
Adolescent
2
2009
22116
0.020
 Why?
Neoplasm Recurrence, Local
1
2014
1075
0.020
 Why?
Homozygote
1
2008
199
0.020
 Why?
Linear Models
1
2010
855
0.020
 Why?
Odds Ratio
1
2010
1057
0.020
 Why?
Amino Acid Substitution
1
2008
308
0.020
 Why?
Colonic Neoplasms
1
2009
244
0.020
 Why?
Aged, 80 and over
1
2019
7948
0.020
 Why?
Reverse Transcriptase Polymerase Chain Reaction
1
2008
983
0.020
 Why?
Cells, Cultured
1
2013
4149
0.010
 Why?
Erythroid-Specific DNA-Binding Factors
1
2005
15
0.010
 Why?
Environmental Exposure
1
2009
579
0.010
 Why?
Comorbidity
1
2010
1671
0.010
 Why?
Aneuploidy
1
2005
88
0.010
 Why?
Genome-Wide Association Study
1
2010
1408
0.010
 Why?
Retrospective Studies
1
2014
16447
0.010
 Why?
Antineoplastic Combined Chemotherapy Protocols
1
2005
1791
0.010
 Why?
Pine's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (308) concept(s)
_
Co-Authors Expand Description
See all (9) people
_
Similar People Expand Description
See all (60) people
_
Same Department Expand Description
Search Department

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)